Nu-Med Plus (NUMD) Capital Expenditures (QoQ) (2012 - 2013)

Nu-Med Plus (NUMD) Capital Expenditures (QoQ) (2012 - 2013) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.47 Bn	176.17 Bn	6.27 Bn
2	Stryker	128.89 Bn	126.01 Bn	3.81 Bn
3	Medtronic	108.71 Bn	99.49 Bn	6.41 Bn
4	Boston Scientific	68.50 Bn	67.05 Bn	3.61 Bn
5	Edwards Lifesciences	48.59 Bn	44.92 Bn	1.29 Bn
6	Dexcom	28.40 Bn	27.29 Bn	750.30 Mn
7	GE HealthCare Technologies	28.34 Bn	26.06 Bn	1.98 Bn
8	Smith & Nephew	26.93 Bn	26.35 Bn	-
9	Koninklijke Philips	25.50 Bn	22.37 Bn	2.07 Bn
10	Nu-Med Plus	1.67 Mn	1.67 Mn	-

Download Data